Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
08/03/2000 | CA2358964A1 Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
08/03/2000 | CA2357735A1 Modulation of immune response by ribavirin |
08/02/2000 | EP1023904A2 Adjuvants for use in vaccines |
08/02/2000 | EP1023903A1 Use of life attenuated bacteria for the manufacture of a submucosal vaccine |
08/02/2000 | EP1023445A1 Cadherin derived growth factor and the application thereof |
08/02/2000 | EP1023322A1 Novel npy family member |
08/02/2000 | EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
08/02/2000 | EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
08/02/2000 | EP1023279A2 Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids |
08/02/2000 | EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
08/02/2000 | EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
08/02/2000 | EP0748222B1 Antitussive composition containing an antitussive and benzydamine |
08/02/2000 | CN1261888A 2{4-[4-(4,5-dichloro-2-methylimidazol-1-yl) butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and therapeutic use |
08/02/2000 | CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists |
08/02/2000 | CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine |
08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
08/02/2000 | CN1261795A Compounds and methods |
08/02/2000 | CN1054998C Clearing away heat and toxic material arresting sleeding powder |
08/02/2000 | CN1054997C Chinese medicinal pill for curing asthmoid respiration |
08/02/2000 | CN1054991C Inhalation for cough and asthma and its preparing method |
08/02/2000 | CN1054990C Tongxuanlifei nourishing liquid for curing cold with cough |
08/02/2000 | CN1054978C Proprietary Chinese traditional medicine for curing asthma and its producing process |
08/01/2000 | US6096774 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, intiators and gas generators |
08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
08/01/2000 | US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
08/01/2000 | US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases |
08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
08/01/2000 | US6096320 Vaccines with chimeric protein comprising gamma-interferon and leukotoxin derived from pasteurella haemolytica |
08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
07/27/2000 | WO2000043495A2 33 human secreted proteins |
07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
07/27/2000 | WO2000043395A1 Substituted porphyrins |
07/27/2000 | WO2000043373A2 Kinase inhibitors |
07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
07/27/2000 | WO2000043026A2 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
07/27/2000 | WO2000043001A1 Anti-inflammatory agents |
07/27/2000 | WO2000042993A2 Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery |
07/27/2000 | WO2000042852A1 Compounds and methods |
07/27/2000 | WO2000025723A3 Methods and compositions for the prevention of tolerance to medications |
07/27/2000 | WO2000011171A3 Human rna-associated proteins |
07/27/2000 | WO1999066944A9 Methods for identifying novel multimeric agents that modulate receptors |
07/27/2000 | CA2361276A1 Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation |
07/27/2000 | CA2361272A1 33 human secreted proteins |
07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |
07/27/2000 | CA2359680A1 Kinase inhibitors |
07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
07/27/2000 | CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery |
07/27/2000 | CA2358093A1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/27/2000 | CA2357781A1 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
07/26/2000 | EP1021549A2 SENSE mRNA THERAPY |
07/26/2000 | EP1021447A1 Pyrrolopyrazolopyrimidine compound and medicine comprising the same |
07/26/2000 | EP1021429A1 Aryl furan derivatives as pde iv inhibitors |
07/26/2000 | EP1021423A1 MACROCYCLIC INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF$g(a) SECRETION |
07/26/2000 | EP1021199A1 PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
07/26/2000 | EP1021196A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
07/26/2000 | EP1021181A1 Carboxylic acid indole inhibitors of chemokines |
07/26/2000 | CN1261403A Surface exposed proteins from chlamydia pneumoniae |
07/26/2000 | CN1261367A Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
07/26/2000 | CN1261352A New 'beta'-amino and 'beta'-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor an tagonists |
07/26/2000 | CN1261277A Novel substituted imidazole compounds |
07/26/2000 | CN1260995A Chinese medicine for treating asthma, chronic bronchitis, pneumonectasis and pneumocardinal diseases |
07/26/2000 | CN1260991A Drops for curing cold |
07/26/2000 | CN1054850C Piperazine compounds used in therapy |
07/26/2000 | CN1054757C Baishi heat-cleaning granule |
07/26/2000 | CN1054752C Anti-virus heat-cleaning oral liquid |
07/26/2000 | CN1054749C Antin sthmatic paper stuck on acupoint |
07/26/2000 | CA2296965A1 Use of bacterium for manufacture of a vaccine |
07/25/2000 | US6093838 Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
07/25/2000 | US6093746 Administering creatine |
07/25/2000 | US6093730 Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals |
07/25/2000 | US6093716 Substituted 2-pyrimidineamines and processes for their preparation |
07/25/2000 | US6093696 N-acetyl-d-thioproline-(o-2,6-dichlorobenzyl)-l-tyrosine, for example; selectively inhibit the alpha 4 subgroup of integrins from binding to their ligands; use in prophylaxis or treatment of immune or inflammatory diseases |
07/25/2000 | US6093561 Human lysophospholipase |
07/25/2000 | US6093532 Method for storing a biological organ transplant graft using a benzisoselen-azoline or -azine compound |
07/25/2000 | CA2197086C (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
07/20/2000 | WO2000042072A2 Polypeptide variants with altered effector function |
07/20/2000 | WO2000042071A2 Compounds and methods to inhibit or augment an inflammatory response |
07/20/2000 | WO2000042054A1 2,3-o-isopropylidene derivatives of monosaccharides as cell adhesion inhibitors |
07/20/2000 | WO2000042053A1 Derivatives of monosaccharides as cell adhesion inhibitors |
07/20/2000 | WO2000042035A1 4-(heterocyclylsulfonamido) -5-methoxy-6- (2-methoxyphenoxy) -2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
07/20/2000 | WO2000042034A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
07/20/2000 | WO2000042023A1 Substituted imidazoles, their preparation and use |
07/20/2000 | WO2000042022A1 Benzoheterocycles and their use as mek inhibitors |
07/20/2000 | WO2000042020A1 Phenylphenanthridines with pde-iv inhibiting activity |
07/20/2000 | WO2000042019A1 6-arylphenanthridines with pde-iv inhibiting activity |
07/20/2000 | WO2000042018A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
07/20/2000 | WO2000042017A1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
07/20/2000 | WO2000042013A1 Cinnamamide derivatives and drug compositions containing the same |